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Magnetic field responsive drug release from
magnetoliposomes in biological fluids†
Silvia Nappini,‡a Silvia Fogli,a Benedetta Castroflorio,§a Massimo Bonini,a
Francesca Baldelli Bombellib and Piero Baglioni*a
The final fate of nano-scaled drug delivery systems into the body is highly aﬀected by their interaction
with proteins in biological fluids (serum, plasma, etc.). Nanocarriers dispersed in biological fluids bear a
protein ‘‘corona’’ that covers their surface. Thus, it is extremely important to evaluate the drug release
eﬃciency also in the biological environment where protein-nanocarrier complexes are formed. The
purpose of this work is to determine how drug release from lipid vesicle carriers is influenced by the
interaction with serum proteins, highlighting the importance to test the eﬀectiveness of such systems in
the biological milieu. In particular, this paper describes the magnetically triggered release behaviour of
magnetoliposomes (MLs) dispersed both in aqueous physiological buﬀer and in bovine serum at two
diﬀerent concentrations (10% and 55% v/v) upon exposure to a low-frequency alternating magnetic field
(LF-AMF). We studied the release from MLs loaded with two types of magnetic nanoparticles (MNPs):
citrate coated Fe3O4 and oleic acid coated g-Fe2O3. The permeability in the above-mentioned fluids was
evaluated in terms of the fluorescence self-quenching of carboxyfluorescein (CF) entrapped inside the
liposome aqueous pool. The results showed a strong reduction of the release in biological fluids, in
particular at high serum concentration. We related this decrease to the formation of protein-liposome
complexes that, under LF-AMF exposure, are subjected to destabilization and tend to form aggregates.
Our results clearly highlight the importance of testing the release eﬃciency of self-assembled drug
delivery systems in biological fluids, in order to understand their behaviour in the presence of proteins
and biomolecules.
Introduction
Lipid vesicles are now considered clinically established nano-
scaled systems for the delivery of drugs, nucleic acids or agents
for biomedical applications.1–3 Liposomes found large applic-
ability because of their biocompatibility, flexibility in composi-
tion and size,4 as well as ability to encapsulate both hydrophilic
and hydrophobic molecules into the aqueous pool5,6 or within
the lipid bilayer,7,8 respectively. One of the key features of a
drug carrier is the release of the encapsulated drug selectively at
the target site with an efficient rate.9 In liposomes the diffusion
of the drugs takes place spontaneously through the membrane,
but the drug release rate could also be enhanced by an external
stimulus, such as pH,10 temperature,11 and mechanical ablation
(for example, using low frequency ultrasounds12,13). As we des-
cribed previously, an efficient pathway towards the fast release
of drugs from lipid vesicles is through the encapsulation of
magnetic nanoparticles (MNPs) either in the membrane or
inside the water pool. The release is then triggered by exposure
to an alternating magnetic field (AMF).14,15 The magnetic NPs
embedded inmagnetoliposomes (MLs) can also be used to direct
and accumulate the loaded drug to targeted sites by means of a
magnetic gradient,14,16 eventually followed by the release of the
drug by the application of the AMF.6,14,17,18
Most typically, a high-frequency alternating magnetic field
(HF-AMF, 50–400 kHz) is used to promote local heating of
magnetic NPs (hyperthermia), resulting in the thermal ablation
of cells in their proximity, with limited damage to healthy
tissues.11,14,19–22 Recently, it has been shown that the safer low-
frequency alternating magnetic field (LF-AMF, 0.01–10 kHz) can
also be applied to promote drug release from magnetic nano-
composites.23–26 In our previous studies6,8,15 we studied the
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effect of the LF-AMF on ML permeability in the presence of
both hydrophilic6 and hydrophobic8 cobalt ferrite (CoFe2O4)
NPs loaded in the aqueous pool and in the lipid bilayer,
respectively.
Despite the promising results obtained with MLs in terms of
controlled drug release, there are several barriers that have to
be overcome before their eﬀective use in vivo. The first aspect to
take into account is their behaviour in biological fluids, where,
it is now accepted, nano-surfaces are modified by the adsorp-
tion of biomolecules such as proteins and lipids forming a
biomolecular protein corona.27 Many factors aﬀect the formation
of this corona, such as the surface curvature, size, chemical
composition and protein concentration.28,29 Similarly, proteins
adsorb on the liposome membrane because of both hydrophobic
and electrostatic interactions.30
It is thought that the protein corona determines the fate of the
NPs in vivo, regulating the interactions with cells and causing their
removal from the bloodstream. For example, the adsorption of
opsonins like fibrinogen, IgG, and the complement factor is
believed to promote phagocytosis with the removal of the NPs
from the bloodstream,31 while binding of dysopsonins like human
serum albumin (HSA), apolipoproteins, etc. promotes prolonged
circulation time in blood.32 Furthermore, corona proteins can
physically mask the NP surface, potentially aﬀecting the thera-
peutic eﬀect of molecules, antibodies, DNA oligomers, etc. bound
to the NP surface. On the other hand, recent studies have shown
that the presence of a protein corona could enhance the drug
delivery action of NPs, promoting high payloads. Cifuentes-Rius
et al.33 have shown that the payload release profile of pre-formed
NP-protein corona complexes (nanorods, gold nanobones, and
carbon nanotubes) is strongly aﬀected by diﬀerent biological
environments.33 In particular, fluids rich of hard corona proteins
promoted a faster release of the payload than those bearing soft
corona proteins.
Here, we report a detailed study about the behaviour of
MLs dispersed in serum upon exposure to a LF-AMF in order
to understand how the magnetically triggered release is
influenced by the interaction with serum proteins. MLs were
formed by 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
embedded with two types of NPs: citrate-coated Fe3O4 NPs
and oleic acid-coated g-Fe2O3 NPs. A consistent number of
reports (recently summarized in a comprehensive review34)
have demonstrated that the citrate coating allows for the
encapsulation of magnetic NPs within the liposome lumen,
while the oleic acid coating takes to their embedding at the
level of the lipid bilayer. MLs were dispersed in bovine serum at
diﬀerent protein concentrations (10% and 55% v/v related to
in vitro and in vivo protein concentrations in the biological
environment) and the release was evaluated after exposure
to a 5.7 kHz alternating magnetic field. Control experiments
were performed on the same MLs in aqueous physiological
buﬀer (PBS) and on non-magnetic liposomes. As in previous
reports,6,8,15 the enhancement of liposome permeability upon
LF-AMF exposure was measured as the self-quenching decrease
of the fluorescent molecule carboxyfluorescein (CF) entrapped
in the liposome pool.
Materials and methods
Materials
Iron(III) chloride hexahydrate (97%), iron(II) sulfate hepta-
hydrate (99%), iron pentacarbonyl Fe(CO)5, octyl ether (purity
grade, 99%), oleic acid (99%), trimethylamine N-oxide (98%),
cyclohexane (499.9%), ethyl alcohol (499.8%), sodium hydroxide
solution 33%, hydrogen chloride solution 37%, tetramethyl-
ammoniumhydroxide 25%wt solution in water (TMAOH), sodium
chloride (499.5%), tri-sodium citrate dihydrate (499%), citric
acid monohydrate (499.5%), 5(6)-carboxyfluorescein (CF,c95%
HPLC), chloroform (99.9% HPLC grade), ethylenediaminetetra-
acetic acid (EDTA, 99.5%), and Triton X-100 were purchased
from Sigma-Aldrich. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) was purchased from Avanti polar lipids. HEPES [4-(2-
hydroxyethyl) piperazine-1-ethane-sulfonic acid] (ultrac99.5%)
and concentrated nitric acid (90%) were purchased from Fluka.
Methanol (99.8%) was purchased from Panreac Quimica Sau and
Sephadex G-25 Superfine from Pharmacia Fine Chemicals. Fetal
bovine serum was purchased from HyClone.
All the reagents were used as supplied, except for trimethyl-
amine N-oxide that was dehydrated immediately before use.
Synthesis of citrate coated Fe3O4 nanoparticles
Magnetite (Fe3O4) NPs were prepared by introducing minor
modifications to a method described elsewhere.35 Briefly, a
solution of 1 M FeCl3 (1 ml) in 2 M HCl was added to 4 ml of
2 M Fe2SO4 solution in 2 M HCl. An aqueous solution of NH3
was added dropwise to the mixture under vigorous agitation.
A black precipitate of magnetite was formed immediately. The
particles obtained were separated by magnetic decantation,
washed with water, dispersed in 10 ml of 2 M HCl solution
and stirred for 5 min. The precipitate was separated again by
magnetic decantation and washed several times with water. The
citrate coating of NPs was carried out according to a method
reported in a previous study.6 The precipitate was dispersed in
20 ml of 100 mM citric acid solution and stirred for 1 h at room
temperature. After recollecting the precipitate with the magnet,
NPs were dispersed in 20 mM trisodium citrate (20 ml) and kept
under stirring for 45 min. The obtained particles were sepa-
rated by magnetic decantation and washed several times with
water and acetone in order to remove any excess of citric acid.
The citrate coated NPs were gently dried under a nitrogen gas
flux, dispersed in the buﬀer solution (10 mM PBS, 150 mM
NaCl, pH 7.4) and kept under stirring for 24 h. Finally the dis-
persion was centrifuged at 1000g for 2 min and the supernatant
was dialyzed against water for 24 h through a cellulose dialysis
bag (avg. flat width 23 mm, MWCO 12400, 99.99% retention) in
order to remove non-adsorbed citrate species.
Synthesis of oleic acid coated c-Fe2O3 nanoparticles
Maghemite (g-Fe2O3) NPs were prepared according to the
method previously described by Hyeon et al.36 Oleic acid
(1.197 g, 6 mmol) was added to 15 ml of octyl ether and the
solution was heated up to 100 1C. Iron pentacarbonyl Fe(CO)5
(260 ml, 2 mmol) was then added and the resulting mixture was
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refluxed for 1 h, during which the colour of the solution
changed from orange to brown-black. At the end of this step,
the dispersion of NPs was cooled down to room temperature
and purged with nitrogen. Still under a nitrogen atmosphere,
dehydrated trimethylamine N-oxide (447 mg, 6 mmol) was
added and the dispersion was heated to 130 1C and kept at
this temperature for 2 h. The nitrogen flux was then removed
and the temperature was slowly increased (3 1C min1) up to
the boiling point. After refluxing for 2 hours, the dispersion was
cooled to room temperature. NPs were then collected by adding
ethanol (50 ml) and the dispersion was centrifuged at 6000 rpm.
The precipitate was washed twice with 20 ml of ethanol and then
the dried precipitate was finally dissolved in cyclohexane to
obtain a stable magnetic fluid.
Preparation of liposomes and magnetoliposomes
The preparation of MLs in the presence of both hydrophilic and
hydrophobic NPs has been previously described.6,8,15 The
method is based on lipid film hydration followed by sequential
extrusion.14,37,38 MLs loaded with citrate coated Fe3O4 NPs were
prepared by the evaporation of the solvent from a CHCl3/MeOH
solution of the lipid (POPC); the dry lipid film was hydrated
with a buﬀer solution of carboxyfluorescein (30 mM CF, 10 mM
PBS, 130 mM NaCl, 94 mM NaOH, 1 mM EDTA, pH 7.4) and
Fe3O4 nanoparticles, so to have a lipid concentration of 20 mM.
MLs with hydrophobic g-Fe2O3 NPs were prepared by evapora-
tion of the solvent from a CHCl3/MeOH solution of the lipid and an
aliquot of maghemite NPs coated with oleic acid in cyclohexane;
the dry film was hydrated with the buﬀer solution of CF to have
a lipid concentration of 20 mM. Finally, control liposomes (i.e.
without magnetic NPs) were prepared by adding a buﬀered
solution of CF to the dry lipid film.
The three dispersions were homogenized by vortex mixing and
freeze-thaw six times. Multilamellar polydispersed vesicles were
then sequentially extruded at room temperature through polycarbo-
nate membranes (Whatman, 0.8 mm/0.4 mm/0.2 mm pore size).
Non-entrapped CF and NPs were removed by gel exclusion
chromatography (GEC) using a Sephadex G-25 micro-column
(1ml syringe) saturated with a 20mMPOPC solution. Liposome dis-
persions were eluted by centrifugation at 2000g for 3 minutes with-
out the loss or dilution of the material. The collected fractions were
investigated by DLS and checked for their NP content by ICP-AES.
Inductively coupled plasma-atomic emission spectrometry
(ICP-OES)
A VARIAN 720 OES inductively coupled plasma optical emission
spectrometer (ICP-OES) was used for the determination of Fe
content (ppm) in both magnetite and maghemite fluids, and
inside MLs. The samples were diluted from 0.1 ml to 5.0 ml in
0.1% nitric acid. A calibration curve of standard solutions of Fe
was used (Fe 238.204; 259.940; 234.350 nm). An internal standard
(Ge, 5 ppm, 209.426 nm) was used to correct for matrix eﬀects.
Magnetic field generator
A sinusoidal adjustable magnetic field was generated in the gap
of a broken ferrite ring carrying a solenoid through which an
alternating electric current (AC) from a tone generator was led.
Samples to be treated with the LF-AMF were placed in the
middle of the gap within 1 cm cylindrical quartz cells. Due to the
design of the experimental apparatus, the magnetic field inside
the cell is not isotropic. As a consequence, the sample undergoes
magnetic field gradients that cannot be avoided (see ESI,† Fig. S1
and S2). The temperature of the solutions treated with the LF-AMF
was checked immediately after each treatment, showing that no
bulk hyperthermic eﬀect was generated.
Quasi-elastic light scattering (QELS)
QELS measurements were carried out by means of a 90Plus/
BI-MAS system using a Brookhaven Instrument apparatus
(New York, USA). The light source was a 15 mW solid state
laser (l = 635 nm). Measurements were performed at 25 1C.
Data analysis has been performed according to standard pro-
cedures, and interpreted through a Cumulant expansion of the
field autocorrelation function, arrested to the second order.
Moreover, in order to obtain a distribution w(G) of decay rates,
a non-negatively constrained least squares (NNLS)39 algorithm
was used to invert the experimental data.
From the decay rates, G, through the equation G = Dtq2 which
is valid for diﬀusive modes, we can determine the translational
diﬀusion coeﬃcient, Dt. The diﬀusion coeﬃcients provide access
to the hydrodynamic correlation lengths RH for isotropic particles
through the Stokes–Einstein relationship
Dt = kBT/6pZSRH (1)
where ZS is the solvent viscosity and kB is the Boltzmann
constant. The particle size distributions resulting from QELS
are provided as scattered intensity vs. hydrodynamic diameter
to account for the higher sensitivity of the technique towards
bigger scattering objects.
Zeta potential
Zeta potential analyses were performed using a ZetaPlus system
by means of a 90Plus/BI-MAS system using a Brookhaven
Instrument apparatus (New York, USA). A laser beam (35 mW
solid state laser, l = 635 nm) passes through an optical cell that
carries two electrodes to generate the electric field. Measure-
ments of liposomes and magnetoliposomes dispersed in water
were performed at 25 1C and analyzed by the Smoluchowski
approximation.
Small angle X-ray scattering (SAXS)
SAXS measurements were carried out using a HECUS SWAX-
camera (Kratky) equipped with a position-sensitive detector
(OED 50 M) containing 1024 channels of 54 mm width. An
X-ray generator (Seifert ID-3003), operating at a maximum power
of 2 kW, provides Cu Ka radiation of wavelength 1.542 Å. A 10 mm
thick nickel filter was used to remove the Cu Kb radiation. The
volume between the sample and the detector was kept under
vacuum (P o 1 mBar) during measurements to minimize
scattering from air. Samples were filled into 1 mm quartz
capillaries. Measurements were carried out at 25 1C and tem-
perature was controlled using a Peltier element, with an
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accuracy of 0.1 1C. All scattering curves were corrected for
solvent and empty cell contribution. The data were slit des-
meared by a linear method.40
In SAXS experiments, the scattered radiation intensity, I(Q),
is given by:41
I(Q) = AFP(Q)S(Q) + Ibkg (2)
where A is the amplitude accounting for the instrumental
factor, F is the volume fraction, P(Q) is the intra-particle structure
factor, S(Q) is the inter-particle structural factor accounting for
the mutual particle correlations, Ibkg is the incoherent back-
ground and Q is the scattering vector.
The scattering length densities (SLDs) of magnetic NPs,
liposomes and MLs were calculated from the X-ray scattering
lengths of the atoms, considering the molecular volumes of
phospholipid fragments evaluated by Armen et al.42 The SLD
of each component was kept constant during the fitting of the
experimental data.43
Drug release experiments
Steady-state fluorescence was measured using a LS50B spectro-
fluorimeter (Perkin Elmer, Italy). The emission fluorescence
spectra of CF were recorded between 500 and 610 nm in the
corrected spectrum mode with the excitation wavelength set at
492 nm (slit 2.5 nm). At least 5 scans were averaged for each
spectrum. The release behaviour of MLs and liposomes (diluted
1 : 67 with PBS and bovine serum 10% and 55% v/v) was
followed as a function of the LF-AMF exposure time by measuring
the fluorescence intensity every 10 min for 15 hours. Fluores-
cence experiments were also performed on MLs and liposomes
maintained at the highest temperature reached during the
magnetic treatment, for the same exposure time. The mother
solution of all samples was diluted to the measurement concen-
tration with a solution of Triton X-100 to achieve complete release
of CF through vesicle disruption (IMAX). The release percentage
was calculated from the fluorescence intensity as:
%release = 100[IML(t)  IML(0)]/[IMAX  IML(0)] (3)
where IML(t) is the measured fluorescence intensity, IML(0) is
the fluorescence intensity of the untreated sample, and IMax is
the maximum fluorescence emission after Triton X-100 addition.
However, the interaction of Triton X-100 with serum makes the
direct measurements of IMAX in biological medium very diﬃcult;
for this reason the theoretical value of IMAX for MLs dispersed in
biological fluids was extrapolated from the calibration curves of
CF in serum 10% and 55% v/v using the experimental value of
IMAX obtained for MLs in PBS as reference (see ESI,† Fig. S12).
Results and discussion
Characterization of the magnetic nanoparticles
SAXS spectra of both citrate coated Fe3O4 and oleic acid coated
g-Fe2O3 NPs are reported in Fig. 1 together with the best fitting
curves. Fe3O4 NPs dispersed in PBS were modelled according
to the formalism introduced by Bartlett and Ottewill for
polydispersed spherical particles.44 In this approach, the parti-
cles are described as spherical objects with a uniform scattering
length density and a Schulz distribution of radii.45,46
No structure factors were included in this model as, due to
the low concentration of particles in the dispersions, the inter-
particle scattering eﬀects are negligible. The fitting returned
NPs of about 7.7 nm in radius.
SAXS spectra of g-Fe2O3 NPs dispersed in cyclohexane were
analysed according to the ‘‘pearl necklace’’ model,47 described
in detail in the ESI.† This model was developed to describe the
scattering pattern produced by fractal assemblies of micelles
(i.e. spherical objects) templated by a backbone.41 The struc-
tural parameters extracted by the fitting are reported in Table 1.
The best fitting was obtained for NPs having a radius of about
4.5 nm (a core of 3.3 nm and a shell of 1.2 nm). The resulting
fractal dimension (2.8) clearly indicates that g-Fe2O3 NPs were
arranged into rather compact clusters. Moreover, the correlation
length value of about 31 nm indicates that NP aggregates were
composed of units formed by few NPs. It should be stressed that
the correlation length value should be taken cautiously and it
could represent an under-estimation, as its value approaches the
instrumental limits of our SAXS.
Characterization of magnetoliposomes
MLs and control liposomes were characterized in PBS, 10%
serum and 55% serum by DLS and SAXS measurements. In
Table 2 the main features of the investigated MLs are reported.
Fig. 1 SAXS spectra of citrate coated Fe3O4 in PBS (J) and oleic acid
coated g-Fe2O3 (n) NPs in cyclohexane.
Table 1 Structural features of the magnetic NPs extracted from the SAXS
measurements
Citrate Fe3O4 Oleic acid g-Fe2O3
SAXS fitting Schulz sphere Pearl necklace model
hRi [nm] 7.7  0.1 3.3  0.3
Shell [nm] — 1.2  0.3
Polydispersity 0.3  0.01 0.10  0.02
Fractal dimension, D — 2.8  0.1
NP correlation length, x [nm] — 31.1  0.3
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The loading eﬃciency of CF and MNPs inside MLs was
determined by measuring their concentration before and after
gel exclusion chromatography (GEC) purification.
CF concentration inside MLs was extrapolated from the
fluorescence intensity of the dye after vesicle disruption by
adding Triton X-100. This value corresponds also to the maxi-
mum fluorescence emission (Imax) of the sample when CF is
completely released. The loading eﬃciency (estimated between
4 and 15% depending on the sample) was calculated as the
ratio of CF concentration before (known value) and after GEC
purification.
NPs’ concentration before and after GEC purification was
determined by ICP-OES, and the loading eﬃciency was calcu-
lated as their ratio (see Table 2).
The average hydrodynamic diameters, DH, of the liposomes
in PBS were obtained by fitting the autocorrelation functions
using cumulant analysis. The size distributions obtained by
NNLS analysis are reported in Fig. 2(a). Empty liposomes and
MLs containing citrate coated Fe3O4 NPs resulted in a single
population (monomodal distribution) centred nearly at the same
DH value obtained by the cumulant analysis, MLs containing
oleic acid g-Fe2O3 NPs showed instead the presence of two
populations. The smaller size distribution is consistent with the
presence of the NP clusters found by SAXS, eventually surrounded
by a phospholipid layer to make them stable in a hydrophilic
environment. The other distribution consists of objects larger
than reference liposomes, which could be the result of a partial
aggregation driven by the presence of NPs. DLS analysis of the
same samples was also performed immediately after 15 min of
exposure to the AMF at a frequency of 5.7 kHz. This frequency
was chosen on the base of previous results.6,8,15 DLS analysis of
magnetic-treated samples did not show large variations in the ML
size distribution, except for those loaded with oleic acid-coated
NPs, as shown in Fig. 2(b). The presence of hydrophobic NPs into
the liposome bilayer promotes therefore the aggregation between
vesicles during the AMF exposure, more likely due to local
MNP motions and hyperthermic eﬀects: in fact, previous AC-
susceptibility measurements performed on MLs embedded
with CoFe2O4 NPs showed that, for field frequency higher than
10 Hz, the local hyperthermia is eﬀective.6
DLS analyses were also performed on samples dispersed in
serum at a protein concentration of 10% and 55% v/v, and the
results are reported in Fig. S3 in the ESI.† However, it was very
diﬃcult to evaluate the size distribution of protein-liposome
complexes in serum through DLS measurements due to the
high background signal from the free proteins as reported in
Fig. S4 (ESI†). It was possible to detect the presence of a main
population (not found in pure serum) of objects with a hydro-
dynamic size of about 500 nm in serum 10%, and of about
700 nm in serum 55% (see Fig. S3 in the ESI†). The same
behaviour was observed with both MLs loaded with citrate and
oleic acid coated NPs. Thus, while no definitive conclusions
could be extracted from the DLS analysis in serum, the results
highlighted the formation of aggregates of MLs in the presence
of the proteins and the synergistic eﬀect of the AMF over aggre-
gation (see Fig. S5 in the ESI†). The aggregation of both empty
liposomes and MLs in biological fluids after the magnetic
treatment was also investigated by optical microscopy (see
Fig. S6–S9 in the ESI†). Phase-contrast micrographs showed
large aggregates ranging from 0.2 to 3 mm for liposomes and
from 1 to 10 mm for MLs. These results further confirmed the
effect of the AMF on promoting the formation of large protein-
vesicle agglomerates.












Fe3O4 citrate 62 7.7 178.4 16.36 52
g-Fe2O3 oleic acid 4.78 4.5 116.8 0.45 31
a Types of magnetic nanoparticles (MNPs). b Magnetic NP concen-
tration by ICP-OES after GEC purification. c Average radius of nano-
particles by SAXS analysis. d Average hydrodynamic diameter of MLs
from DLS analysis. e Surface charge of MLs from z-potential analysis.
f Calculated as {[NPs]afterGEC/[NPs]beforeGEC}  100.
Fig. 2 Representative size distributions of liposomes (empty grey bars),
magnetoliposomes with citrate coated Fe3O4 NPs (empty black bars) and
magnetoliposomes with oleic acid coated Fe2O3 NPs (grey bars) dispersed
in PBS from NNL analysis before LF-AMF exposure (a) and after magnetic
treatment at 5.7 kHz for 15 min (b).
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SAXS measurements were carried out to obtain insights into
the local arrangement of the lipid membrane as a function of
NP encapsulation, AFM exposure and incubation in serum.
SAXS spectra of liposomes and MLs loaded with citrate-
coated NPs and oleic acid-coated NPs dispersed in PBS are
reported in Fig. 3, together with the corresponding best fittings.
SAXS spectra of liposomes were analyzed according to a model
proposed by Nallet et al.48 for lamellar phases of the amphi-
philic bilayer. Magnetoliposomes were modelled by taking into
account the scattering intensity arising from both liposomes
(amphiphilic bilayer) andNPs arranged in fractal clusters. Magnetic
NPs were modelled according to the pearl necklace model,41
where each spherical NP has a constant shell thickness and a
core with a Schulz distribution of radii.49 More details about
the models and the fitting parameters are given in the ESI.† The
results from the fitting (Table 3) show that citrate coated Fe3O4
NPs did not significantly aﬀect the structure of the lipid bilayer,
confirming their confinement within the aqueous pool of the
liposomes. On the other hand, the change of both the lipid tail
length and the headgroup thickness in the presence of oleic
acid coated g-Fe2O3 NPs clearly indicates the direct interaction
of NPs with the lipid bilayer.
This could correspond to either a physisorption of MNPs
onto the liposome or an insertion of the MNPs into the lipid
bilayer. In fact, given that g-Fe2O3 NPs diameters exceed the
thickness of the lipid bilayer, the POPC membrane can distort
to accommodate NPs both inside and/or on the surface of the
lipid membrane. This result is consistent with the ability of the
cell membrane to accommodate transmembrane proteins.50
SAXS spectra of liposomes in serum were also recorded (see
Fig. S10 in the ESI†), but the scattered intensity from serum
does not allow for a reliable analysis of the results in terms of
the eﬀect of MNPs on the liposome bilayer.
Release studies with carboxyfluorescein
CF fluorescence was measured over time to investigate the
release properties of untreated samples, and samples exposed
to the LF-AMF for 15 min. Fluorescence emission was related to
CF release and was continuously monitored during the first
1000 minutes (about 16 h) every 10 min and eventually, single
measurements were performed 18, 24 and 40 h after the expo-
sure. Release experiments were performed on the samples dis-
persed in three diﬀerent investigated fluids (PBS, 10% v/v serum
and 55% v/v serum). The experimental data were fitted using the
Ritger–Peppas equation,51,52 a semi-empirical equation used to
describe drug release from polymeric systems:
Mt/MN = Ktn for Mt/MN o 0.6 (4)
where Mt/Mp is the drug fraction released at time t, K is a
kinetic constant that includes the structural and geometric
characteristics of the system, and n is the diﬀusion exponent
indicative of the drug transport mechanism. The power-law
equation can be seen as the superposition of a Fickian diﬀusion
and a zero order kinetics:51,53 n values at around 0.5 indicate
pure Fickian diﬀusion, while n values at around 1.0 indicate
that erosion or relaxation processes lead the release process
(zero-order release, case II transport). Intermediate n values
between 0.5 and 1.0 suggest that both diﬀusion and erosion
contribute to the overall release mechanism (anomalous trans-
port). Occasionally, values of n c 1 have been observed and
considered as kinetics dominated by disruption processes of
the matrix (supercase II transport).
The kinetics of CF release from MLs containing oleic acid-
coated g-Fe2O3 NPs and citrate-coated Fe3O4 NPs are shown in
Fig. 4 and 5, respectively, while those from pristine liposomes
are reported in the ESI† (Fig. S11). The kinetic parameters
obtained from fitting according to eqn (4) are shown in Table 4.
All the samples, including pristine liposomes, showed a lower
release in serum than in PBS (see Fig. 4 and 5), indicating a
trend typical of anomalous transport and zero-order kinetics of
perturbed systems, most likely due to the formation of protein-
vesicle adducts.
Focusing on the release profiles of MLs loaded with oleic
acid g-Fe2O3 NPs, two important aspects should be highlighted.
First of all, the release profiles in buﬀer and serum 10% when
no LF-AMF is applied are very similar. The increase in serum
proteins (serum 55%) significantly aﬀects both the profile and
Fig. 3 SAXS spectra of liposomes (&), magnetoliposomes with citrate
coated Fe3O4 (n) and oleic acid coated g-Fe2O3 (J) nanoparticles.
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Fig. 4 Release kinetics of oleic acid-coated g-Fe2O3 NP embedded-magnetoliposomes for the first 16 h. (J) Untreated samples, and (n)
samples exposed to the AMF for 15 minutes at a frequency of 5.7 kHz in PBS (a), serum 10% v/v (b), and serum 55% v/v (c). Solid curves are
the best fitting obtained by means of eqn (4). Single measurements of the release in PBS (a0), serum 10% v/v (b0), and serum 55% v/v (c0) were taken
for 40 hours.
Fig. 5 Release kinetics of citrate-coated Fe3O4 NP embedded-magnetoliposomes for the first 16 h. (J) Untreated samples, and (n) samples exposed to
the AMF for 15 minutes at a frequency of 5.7 kHz in PBS (a), serum 10% v/v (b), and serum 55% v/v (c). Solid curves are the best fitting obtained by means of
eqn (4). Single measurements of the release in PBS (a0), serum 10% v/v (b0), and serum 55% v/v (c 0) were taken within 40 hours.
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the magnitude of the release profile, clearly suggesting a decrease
in the permeability of the liposomemembrane in the presence of a
higher concentration of serum proteins (see Fig. 4a–c). Analysing
the results in magnetically treated MLs loaded with oleic acid
g-Fe2O3 NPs, it is clear that the presence of serum proteins
strongly mitigates the effect of the LF-AMF. Nevertheless, in all
the samples the application of the LF-AMF induces a significant
increase in the released amount of CF during its application
and in the following few hours. In both 10% and 55% serum
samples, after nearly 15 hours the release is comparable to that
of untreated MLs.
This suggests that the initial release was promoted by the
application of the magnetic field, most likely thanks to the
defects generated at the bilayer level by the motions and the local
heating of MNPs. Once the field was switched oﬀ, the release rate
decreased, reasonably because of a healing eﬀect favoured by the
formation of protein–ML complexes. At very long times (i.e., after
40 hours) the behaviour is inverted, with magnetically treated
MLs showing a released amount lower than the corresponding
untreated samples. This behaviour further suggests an effect
of the MNPs at the membrane level and a stabilization of the
bilayer due to serum. The release from MLs loaded with citrate-
coated Fe3O4 NPs is even more affected by the presence of
serum (see Fig. 5a–c). The effect of the LF-AMF on the released
amount in PBS is very similar to what was observed with
g-Fe2O3 NPs, with a magnitude of the release nearly halved,
even though the profiles are similar. When serum is present at
10%, the release from untreated MLs is nearly identical to that
in PBS, while increasing the amount of serum at 55% brings a
significant increase in the magnitude of release even without
the magnetic field. This can be explained by the aggregation of
MLs in the presence of a consistent amount of serum proteins
and the consequent destabilization of the bilayer. This behaviour
was not observed with g-Fe2O3 NPs, most likely because of the
direct interaction of the hydrophobic particles with the bilayer.
When serum is present at 10%, the results show no eﬀect of
the LF-AMF on citrate-coated Fe3O4 NPs, while the sample with
serum at 55% shows a lower release when the LF-AMF is applied,
converging at long times to the same value found when no
LF-AMF is applied. These results demonstrate that the applica-
tion of the magnetic field in the presence of both citrate-coated
Fe3O4 NPs and serum proteins induces a significant decrease in
the membrane permeability thanks to the magnetically induced
exposition of the particles towards the continuous phase sur-
rounding the MLs. The surface reactivity of Fe3O4 NPs (citrate is
weakly coordinated to their surface) makes them very likely
to get coated by serum proteins already at the bilayer level,
eventually making it less permeable.
The low response of MLs loaded with citrate-coated Fe3O4
NPs dispersed in serum can be also associated with the higher
concentration of hydrophilic NPs that can be encapsulated in
MLs in comparison to the hydrophobic ones. It is clear that a
larger number of NPs promote serum protein adsorption on
the ML membrane, thus the formation of larger serum–ML
Table 4 Kinetic parameters obtained by fitting CF release curves from magnetoliposomes according to eqn (4)
MLs with oleic acid g-Fe2O3 NPs MLs with citrate Fe3O4 NPs
PBS
No field n 0.55  0.01 0.71  0.01
K 8.67  103  0.88  103 1.16  103  0.07  103
LF-AFM n 0.87  0.01 0.82  0.01
K 4.66  104  0.26  104 7.21  104  0.37  104
SERUM 10% v/v
No field n 0.44  0.01 0.44  0.01
K 2.47  102  0.20  102 8.5  103  0.03  103
LF-AFM n 0.63  0.01 0.68  0.01
K 1.70  105  0.16  103 1.06  103  0.01  103
SERUM 55% v/v
No field n 0.66  0.01 0.41  0.01
K 3.13  103  0.03  103 2.65  102  0.10  102
LF-AFM n 0.99  0.01 0.77  0.03
K 1.69  104  0.02  103 1.58  103  0.29  103
Fig. 6 Schematic graph of the diﬀusion exponent n extrapolated from the
fitting of the kinetic curves with the Ritger–Peppas equation.
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aggregates that hinder the CF release, resulting in a low
response to the LF-AMF.
In terms of the diﬀusion exponent n, the results are summar-
ized in Fig. 6 to make their comparison easier. All the investi-
gated samples display a release kinetic that ranges between the
Fickian and the anomalous mechanism.
Furthermore, irrespective of the type of magnetic nano-
particle used and the presence of serum proteins, all the samples
display an increase of the n value when the LF-AMF is applied.
The results clearly suggest the generation of anomalous release
pathways at the level of the ML membrane. In particular, the
sample with serum 55% and g-Fe2O3 NPs after the LF-AMF
treatment displays the highest n value among the investigated
samples, indicating a major change in the structure of the ML
membrane. These results further highlight the importance of the
surface properties of MNPs in the design of remotely triggerable
drug delivery vehicles, as well as the crucial role of serum in
modulating the LF-AMF eﬀect.
Conclusions
In this work we report on the preparation, the characterization
and the magnetically triggered drug release properties of mag-
netoliposomes (MLs) prepared either with oleic acid-coated
g-Fe2O3 or citrate-coated Fe3O4 magnetic nanoparticles (MNPs)
and dispersed in biological fluids. The investigation was carried
out in order to evaluate how the eventual interaction of phos-
pholipid vesicles and magnetic nanoparticles with biological
fluids aﬀects the aggregation and the release properties of MLs,
especially when they are subjected to a low frequency alternat-
ing magnetic field (LF-AMF).
The co-extrusion of MNPs brings an increase in the average
size of liposomes when citrate-coated Fe3O4 magnetic nano-
particles are used, also accompanied by an increase in the
polydispersity in the case of oleic-acid coated g-Fe2O3 NPs. No
major changes are observed in response to the application of the
LF-AMF when MNPs are located within the water pool (citrate
coated Fe3O4 NPs), while aggregation between MLs and a con-
sequent increase in the average size are observed whenMNPs are
located in the proximity of the ML bilayer (oleic acid coated
g-Fe2O3 NPs).
The surface functionalization of MNPs and their consequent
localization in the ML water pool or at the membrane level are
also crucial for the release properties. Hydrophobic MNPs could
be uploaded in a much smaller amount with respect to hydro-
philic nanoparticles, consistent with the much larger volume
available in the water pool than in the proximity of the bilayer.
Nevertheless, the eﬀect of oleic-acid coated NPs is significantly
stronger than that of citrate-coated NPs. Furthermore, their
eﬀect is retained also in the presence of serum proteins.
The comparison between the results obtained in PBS buﬀer
with those in the presence of serum proteins shows a clear decrease
in the permeability of the membrane. The typical increase in
the amount of released drug when the LF-AMF is applied is
strongly dampened as a function of the serum concentration,
suggesting a healing eﬀect at the membrane level. Nevertheless,
when g-Fe2O3 NPs are used the magnetic responsivity is retained,
while this is nearly lost with citrate coated Fe3O4 NPs.
Considering the obtained results, the importance of testing
the release eﬃciency of self-assembled drug delivery systems in
biological fluids is clear, in order to understand their behaviour
in the presence of proteins and biomolecules that can interact
with them. In particular, the surface properties of MNPs are
crucial for their localization in liposomes either in the water
pool or at the membrane level. As a consequence, the eﬀect of
the LF-AMF on the drug release properties is strongly diﬀerent,
demonstrating how the hydrophilicity/hydro-phobicity of the MNP
surface is a key parameter to tune the membrane permeability.
Here, it still remains unclear if the major destabilization
observed after magnetic exposure in the biological fluids was
directly bound to the protein adsorption or to a combined eﬀect
of a first destabilization of the membrane due to the presence
of MNPs, which led to a further extensive agglomeration.
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